You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 00078-0939


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00078-0939

Drug NameNDCPrice/Unit ($)UnitDate
VIGAMOX 0.5% EYE DROPS 00078-0939-26 31.51675 ML 2024-11-14
VIGAMOX 0.5% EYE DROPS 00078-0939-26 63.96612 ML 2024-09-18
VIGAMOX 0.5% EYE DROPS 00078-0939-26 63.98226 ML 2024-08-21
VIGAMOX 0.5% EYE DROPS 00078-0939-26 64.00091 ML 2024-07-17
VIGAMOX 0.5% EYE DROPS 00078-0939-26 63.98566 ML 2024-06-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 00078-0939

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
VIGAMOX 0.05%SOLN,OPH Novartis Pharmaceuticals Corporation 00078-0939-26 3ML 174.12 58.04000 2021-11-23 - 2025-08-31 FSS
VIGAMOX 0.05%SOLN,OPH Novartis Pharmaceuticals Corporation 00078-0939-26 3ML 174.12 58.04000 2022-01-01 - 2025-08-31 FSS
VIGAMOX 0.05%SOLN,OPH Novartis Pharmaceuticals Corporation 00078-0939-26 3ML 129.52 43.17333 2022-01-01 - 2025-08-31 Big4
VIGAMOX 0.05%SOLN,OPH Novartis Pharmaceuticals Corporation 00078-0939-26 3ML 129.26 43.08667 2023-01-01 - 2025-08-31 Big4
VIGAMOX) 0.5% SOLN,OPH Harrow Eye, LLC 00078-0939-26 3ML 126.11 42.03667 2024-03-15 - 2029-03-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 5 of 5 entries

Market Analysis and Price Projections for the Drug NDC: 00078-0939

Understanding the NDC Directory

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand the role of the NDC Directory. The NDC Directory, maintained by the FDA, contains information on all listed drugs in their final marketed form, including prescription, over-the-counter (OTC), approved, and unapproved drugs[1][5].

Identifying the Drug

The NDC 00078-0939 corresponds to a specific drug product. To identify this drug, one would typically search the FDA's NDC Directory using the NDC number. This search would provide details such as the proprietary name, non-proprietary name, dosage form, route of administration, and other relevant information[1][5].

Market Dynamics

Prescription Drug Market Overview

The pharmaceutical market, including both prescription and OTC drugs, is influenced by several factors:

  • High Cost of Prescription Drugs: The high cost of prescription drugs is a significant driver for the shift towards OTC drugs. Many individuals opt for OTC alternatives due to the unaffordability of prescription medications. For instance, a study by the Kaiser Family Foundation indicated that almost one in three US individuals does not take medication as prescribed due to high costs[4].

  • Price Increases: Prescription drug prices have seen substantial increases. In 2022, over 1,216 drugs witnessed price hikes, with some increasing by more than 500%[4].

Impact on Specific Drugs

For a drug with the NDC 00078-0939, several factors would influence its market dynamics and price projections:

  • Competition: The presence of generic or OTC alternatives can significantly impact the pricing of a prescription drug. If the drug has generic versions or OTC equivalents, this could lead to price competition and potentially lower prices[4].

  • Regulatory Environment: Regulatory policies and transparency requirements, such as those in Oregon's Drug Price Transparency Program, can affect how drug prices are set and reported. Manufacturers must report price increases and provide reasons for these increases, which can influence public perception and regulatory actions[2].

  • Supply Chain Factors: The pharmaceutical supply chain, including interactions between manufacturers, pharmacy benefit managers (PBMs), and other entities, plays a crucial role in determining drug prices. Factors such as rebates, discounts, and markups can significantly impact the final cost to consumers[2].

Price Projections

Current Pricing Trends

Given the current trends in the pharmaceutical market:

  • Generic Drug Price Increases: Generic drugs have seen significant price increases, with a median increase of 19.9% in 2022. If the drug with NDC 00078-0939 is a generic or has generic competitors, it may be subject to similar price fluctuations[2].

  • Brand Name Drug Pricing: Brand name drugs also experience price increases, with a median increase of 13.4% in 2022. If the drug is a brand name product, it could follow this trend unless there are specific market or regulatory factors that influence its pricing differently[2].

Future Pricing Considerations

  • Regulatory Changes: Potential regulatory changes, such as the implementation of upper payment limits or increased transparency across the pharmaceutical supply chain, could impact future pricing. These changes aim to make drugs more affordable and could reduce price volatility[2].

  • Market Competition: New approvals and launches in the OTC drugs market can shift consumer preferences and impact the pricing of prescription drugs. If the drug with NDC 00078-0939 faces increased competition from OTC alternatives, its price might be pressured downward[4].

NDC Format Changes

The FDA is facing a shortage of NDC numbers and is considering changes to the NDC format. This change could have widespread implications for the pharmaceutical industry, including how drugs are identified, tracked, and priced. However, this is more of a structural change rather than a direct influence on pricing[3].

Key Takeaways

  • Market Dynamics: The market for prescription drugs is heavily influenced by factors such as high costs, regulatory transparency, and supply chain interactions.
  • Price Trends: Generic and brand name drugs have seen significant price increases, with generics experiencing higher median increases.
  • Regulatory Impact: Regulatory changes and increased transparency can impact drug pricing and affordability.
  • Competition: The rise of OTC alternatives can pressure prescription drug prices downward.

FAQs

  1. What is the NDC Directory, and how does it help in identifying drugs?

    • The NDC Directory is a database maintained by the FDA that contains information on all listed drugs in their final marketed form. It helps in identifying drugs by providing details such as the proprietary name, dosage form, and route of administration using the unique NDC number[1][5].
  2. How do high prescription drug costs affect the market?

    • High prescription drug costs lead to a shift towards OTC drugs and can result in non-adherence to prescribed medications due to unaffordability. This shift impacts the demand for prescription drugs and can influence pricing strategies[4].
  3. What role do regulatory policies play in drug pricing?

    • Regulatory policies, such as those in Oregon's Drug Price Transparency Program, require manufacturers to report price increases and provide reasons for these increases. This transparency can influence public perception and regulatory actions, potentially affecting drug prices[2].
  4. How does the pharmaceutical supply chain impact drug prices?

    • The supply chain, including interactions between manufacturers, PBMs, and other entities, influences drug prices through factors such as rebates, discounts, and markups. These interactions can significantly impact the final cost to consumers[2].
  5. What are the potential impacts of changing the NDC format on drug pricing?

    • The change in NDC format is more of a structural adjustment and is not expected to have a direct impact on drug pricing. However, it could affect how drugs are identified, tracked, and managed within the pharmaceutical supply chain[3].

Sources

  1. FDA's New NDC Directory - YouTube
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon's Drug Price Transparency Program
  3. Are You Prepared for a Major Industry Change to the National Drug Code (NDC) Number? - Wolters Kluwer
  4. U.S. OTC Drugs Market Forecast Report 2024-2029 - GlobeNewswire
  5. National Drug Code Directory - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.